| 存储条件 |
|---|
| Product Name | B3GAT1 [B10-B8] |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | 3-glucuronyltransferase 1 antibody 3-glucuronyltransferase antibody B3GA1_HUMAN antibody B3gat1 antibody Beta 1 3 glucuronyltransferase 1 antibody Beta-1 antibody Beta-1,3-glucuronyltransferase 1 antibody CD 57 antibody CD57 antibody CD57 antigen antibody Galactosylgalactosylxylosylprotein 3 beta glucuronosyltransferase 1 antibody Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 antibody GlcAT P antibody GlcAT-P antibody GLCATP antibody GlcUAT P antibody GlcUAT-P antibody GlcUATP antibody Glucuronosyltransferase P antibody HNK 1 antibody HNK1 antibody LEU 7 antibody LEU7 antibody LEU7 antigen antibody NK 1 antibody NK1 antibody UDP GlcUA glycoprotein beta 1 3 glucuronyltransferase antibody UDP-GlcUA:glycoprotein beta-1 antibody |
| Product description | Over 100 cell surface markers have been identified through the use of monoclonal antibodies. Many of these markers have proven useful in identifying a specific subpopulation of cells within a mixed colony. Accordingly, these molecules have been assigned a "cluster of differentiation" (CD) designation. T lymphocytes displaying the natural killer (NK) cell marker CD57 (also designated Leu7 or B3GAT1) on their cell surface are distinguishable from other T cell subsets by their granular lymphocyte morphology and their clonal expansion in patients with AIDS and in recipients of bone marrow transplantation. CD57-positive cells have also been shown to localize to sites of certain tumors and large numbers of these cells are detected in the synovial fluid from patients suffering from rheumatoid arthritis. |
| Immunogen | Recombinant protein |
| Clonality | Monoclonal |
|---|---|
| Isotype | IgG1 |
| Host Species | Mouse |
| Tested Applications | WBFC |
| WB:1:500-1:2,000 FC:1:100-1:200 | |
| Species Reactivity | Human |
| Concentration | 2mg/ml |
| Alternative Names | 3-glucuronyltransferase 1 antibody 3-glucuronyltransferase antibody B3GA1_HUMAN antibody B3gat1 antibody Beta 1 3 glucuronyltransferase 1 antibody Beta-1 antibody Beta-1 3-glucuronyltransferase 1 antibody CD 57 antibody CD57 antibody CD57 antigen antibody Galactosylgalactosylxylosylprotein 3 beta glucuronosyltransferase 1 antibody Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 antibody GlcAT P antibody GlcAT-P antibody GLCATP antibody GlcUAT P antibody GlcUAT-P antibody GlcUATP antibody Glucuronosyltransferase P antibody HNK 1 antibody HNK1 antibody LEU 7 antibody LEU7 antibody LEU7 antigen antibody NK 1 antibody NK1 antibody UDP GlcUA glycoprotein beta 1 3 glucuronyltransferase antibody UDP-GlcUA:glycoprotein beta-1 antibody |
|---|---|
| Molecular Weight(MW) | 38 kDa |
| Cellular Localization | Golgi apparatus membrane |
| SwissProt ID | Q9P2W7 |
|---|
Application
Fig1: Western blot analysis of B3GAT1 on human B3GAT1 recombinant protein using anti-B3GAT1 antibody at 1/1,000 dilution.
Application
Fig2: Western blot analysis of B3GAT1 on HEK293 (1) and B3GAT1-hIgGFc transfected HEK293 (2) cell lysate using anti-B3GAT1 antibody at 1/1,000 dilution.
Application
Fig3: Western blot analysis of B3GAT1 on different cell lysate using anti-B3GAT1 antibody at 1/1,000 dilution. Positive control： Lane1: MOLT4 Lane2: Raji Lane3: Ramos
Application
Fig4:Flow cytometric analysis of Hela cells with B3GAT1 antibody at 1/100 dilution (green) compared with an unlabelled control (cells without incubation with primary antibody; red).| Positive Control | Human B3GAT1 recombinant protein, human B3GAT1 recombinant protein, MOLT4, Raji, Ramos, Hela. |
|---|---|
| Application Notes | WB:1:500-1:2,000 FC:1:100-1:200 |
| Form | Liquid |
|---|---|
| Storage Instructions | Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles. |
| Storage Buffer | 1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide. |
抱歉，暂无相关文献
